Section of Cardiothoracic Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202-5123, USA.
Ann Thorac Surg. 2011 Jan;91(1):188-93; discussion 193-4. doi: 10.1016/j.athoracsur.2010.07.057.
The optimal surgical treatment of patients with transposition of the great arteries, ventricular septal defect, and pulmonary stenosis is controversial. Although the Rastelli operation has been standard surgical management of this lesion, aortic root translocation with right ventricular outflow tract (RVOT) reconstruction (Nikaidoh) and the pulmonary artery translocation (Lecompte) or REV (réparation a l'étage ventriculaire) are surgical alternatives more recently introduced to treat this complex lesion. This report reviews our 20-year experience with the Rastelli procedure and attempts to compare our outcomes with those recently published using the Nikaidoh and REV procedures.
Between 1988 and 2008, 40 patients (median age, 4 years; range, 9 months to 17 years) underwent Rastelli operation at our institutions. The RVOT was obstructed in 32 and atretic in 8. Follow-up was available for all but one patient (mean follow-up, 8.6±5.6 years). The RVOT was reconstructed with homograft (n=25), bovine jugular vein (n=8), nonvalved Dacron tube (n=5), or a porcine valved conduit (n=2). Two patients required a pacemaker.
There were no early, but three late deaths and one heart transplantation 12 years postoperative the Rastelli operation. Kaplan-Meier survival was 93% at 5, 10, and 20 years. Univariate risk factors for death or transplantation included surgery before 1998 (p=0.03) and concomitant noncardiac anomalies (p=0.001). Sixteen patients (40%) had reoperation for right ventricular-pulmonary artery conduit stenosis (mean, 7.8±3.8 years) without mortality. Freedom from conduit replacement was 86%, 74%, 63%, and 59% at 5, 10, 15, and 20 years, respectively. Multivariate analysis revealed that the risk factors of conduit replacement were younger age at operation (p=0.001) and surgery before 1998 (p<0.001). Two patients (5%) required reoperation for left ventricular outflow tract obstruction. At follow-up, there were no sudden unexplained deaths, and New York Heart Association functional class is I or II.
The Rastelli procedure is a low-risk operation with regard to early and late mortality and reoperation for left ventricular outflow tract obstruction. Conduit change operations will be required in most patients regardless of the technique of repair, but currently can be performed with low morbidity and mortality. These midterm outcomes after the Rastelli operation should serve as a basis for comparison with surgical alternatives more recently introduced for transposition of the great arteries and ventricular septal defect with RVOT obstruction.
大动脉转位、室间隔缺损伴肺动脉瓣狭窄患者的最佳手术治疗方法存在争议。虽然 Rastelli 手术一直是该病变的标准手术治疗方法,但主动脉根部移位伴右心室流出道(RVOT)重建(Nikaidoh)、肺动脉移位(Lecompte)或 REV(心室水平修复)最近也被引入用于治疗这种复杂病变。本报告回顾了我们 20 年的 Rastelli 手术经验,并尝试比较我们的结果与最近使用 Nikaidoh 和 REV 手术的结果。
1988 年至 2008 年间,40 例患者(中位年龄 4 岁;年龄范围 9 个月至 17 岁)在我们机构接受了 Rastelli 手术。32 例 RVOT 存在梗阻,8 例存在闭锁。除 1 例患者外,所有患者均获得随访(平均随访时间 8.6±5.6 年)。RVOT 重建采用同种异体移植物(n=25)、牛颈静脉(n=8)、无瓣 Dacron 管(n=5)或猪瓣导管(n=2)。2 例患者需要起搏器。
无早期死亡,但有 3 例晚期死亡和 1 例心脏移植,发生在 Rastelli 手术后 12 年。Rastelli 手术的 Kaplan-Meier 生存曲线显示,术后 5、10 和 20 年的生存率分别为 93%、93%和 93%。死亡或移植的单因素风险因素包括 1998 年前手术(p=0.03)和合并非心脏畸形(p=0.001)。16 例(40%)因右心室-肺动脉导管狭窄而再次手术(平均 7.8±3.8 年),无死亡。无导管置换的生存率分别为 86%、74%、63%和 59%,术后 5、10、15 和 20 年。多因素分析显示,导管置换的危险因素是手术时年龄较小(p=0.001)和 1998 年前手术(p<0.001)。2 例(5%)患者因左心室流出道梗阻需要再次手术。随访时,无突发性不明原因死亡,纽约心脏协会功能分级为 I 或 II 级。
Rastelli 手术在早期和晚期死亡率以及左心室流出道梗阻再手术方面风险较低。无论修复技术如何,大多数患者都需要进行导管更换手术,但目前可以以较低的发病率和死亡率进行。Rastelli 手术后的这些中期结果应作为与最近引入的大动脉转位和伴有 RVOT 梗阻的室间隔缺损的手术替代方法进行比较的基础。